Renal Denervation Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

CHAPTER 1. Industry Overview of Renal Denervation Market

1.1. Definition and Scope

1.1.1. Definition of Renal Denervation

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Renal Denervation Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Renal Denervation Market By Product Type

1.2.3. Renal Denervation Market By Technology

1.2.4. Renal Denervation Market By Indication

1.2.5. Renal Denervation Market By End-User

1.2.6. Renal Denervation Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Renal Denervation Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Renal Denervation Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2021

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Renal Denervation Market By Product Type

4.1. Introduction

4.2. Renal Denervation Revenue By Product Type

4.2.1. Renal Denervation Revenue (USD Million) and Forecast, By Product Type, 2018-2030

4.2.2. Symplicity

4.2.2.1. Symplicity Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.3. Enlightn

4.2.3.1. Enlightn Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.4. Vessix

4.2.4.1. Vessix Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.5. Paradise

4.2.5.1. Paradise Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.6. Iberis

4.2.6.1. Iberis Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.7. Others

4.2.7.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 5. Renal Denervation Market By Technology

5.1. Introduction

5.2. Renal Denervation Revenue By Technology

5.2.1. Renal Denervation Revenue (USD Million) and Forecast, By Technology, 2018-2030

5.2.2. Micro-Infusion

5.2.2.1. Micro-Infusion Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.3. Ultrasound

5.2.3.1. Ultrasound Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.4. Radiofrequency

5.2.4.1. Radiofrequency Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 6. Renal Denervation Market By Indication

6.1. Introduction

6.2. Renal Denervation Revenue By Indication

6.2.1. Renal Denervation Revenue (USD Million) and Forecast, By Indication, 2018-2030

6.2.2. Hypertension

6.2.2.1. Hypertension Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.3. Heart Failure

6.2.3.1. Heart Failure Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.4. Diabetes

6.2.4.1. Diabetes Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.5. Renal Failure

6.2.5.1. Renal Failure Market Revenue (USD Million) and Growth Rate (%), 2018-2030 BFSI

CHAPTER 7. Renal Denervation Market By End-User

7.1. Introduction

7.2. Renal Denervation Revenue By End-User

7.2.1. Renal Denervation Revenue (USD Million) and Forecast, By End-User, 2018-2030

7.2.2. Hospitals

7.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2018-2030

7.2.3. Specialty Clinics

7.2.3.1. Specialty Clinics Market Revenue (USD Million) and Growth Rate (%), 2018-2030

7.2.4. Others

7.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 8. North America Renal Denervation Market By Country

8.1. North America Renal Denervation Market Overview

8.2. U.S.

8.2.1. U.S. Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

8.2.2. U.S. Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

8.2.3. U.S. Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

8.2.4. U.S. Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

8.3. Canada

8.3.1. Canada Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

8.3.2. Canada Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

8.3.3. Canada Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

8.3.4. Canada Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

8.4. North America PEST Analysis

CHAPTER 9. Europe Renal Denervation Market By Country

9.1. Europe Renal Denervation Market Overview

9.2. U.K.

9.2.1. U.K. Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

9.2.2. U.K. Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

9.2.3. U.K. Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

9.2.4. U.K. Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

9.3. Germany

9.3.1. Germany Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

9.3.2. Germany Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

9.3.3. Germany Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

9.3.4. Germany Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

9.4. France

9.4.1. France Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

9.4.2. France Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

9.4.3. France Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

9.4.4. France Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

9.5. Spain

9.5.1. Spain Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

9.5.2. Spain Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

9.5.3. Spain Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

9.5.4. Spain Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

9.6. Rest of Europe

9.6.1. Rest of Europe Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

9.6.2. Rest of Europe Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

9.6.3. Rest of Europe Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

9.6.4. Rest of Europe Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Renal Denervation Market By Country

10.1. Asia Pacific Renal Denervation Market Overview

10.2. China

10.2.1. China Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

10.2.2. China Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

10.2.3. China Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

10.2.4. China Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

10.3. Japan

10.3.1. Japan Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

10.3.2. Japan Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

10.3.3. Japan Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

10.3.4. Japan Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

10.4. India

10.4.1. India Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

10.4.2. India Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

10.4.3. India Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

10.4.4. India Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

10.5. Australia

10.5.1. Australia Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

10.5.2. Australia Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

10.5.3. Australia Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

10.5.4. Australia Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

10.6. South Korea

10.6.1. South Korea Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

10.6.2. South Korea Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

10.6.3. South Korea Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

10.6.4. South Korea Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

10.7.2. Rest of Asia-Pacific Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

10.7.3. Rest of Asia-Pacific Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

10.7.4. Rest of Asia-Pacific Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Renal Denervation Market By Country

11.1. Latin America Renal Denervation Market Overview

11.2. Brazil

11.2.1. Brazil Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

11.2.2. Brazil Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

11.2.3. Brazil Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

11.2.4. Brazil Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

11.3. Mexico

11.3.1. Mexico Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

11.3.2. Mexico Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

11.3.3. Mexico Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

11.3.4. Mexico Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

11.4. Rest of Latin America

11.4.1. Rest of Latin America Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

11.4.2. Rest of Latin America Renal Denervation Revenue (USD Million) and Forecast By, 2018-2030

11.4.3. Rest of Latin America Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

11.4.4. Rest of Latin America Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Renal Denervation Market By Country 

12.1. Middle East & Africa Renal Denervation Market Overview

12.2. GCC

12.2.1. GCC Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

12.2.2. GCC Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

12.2.3. GCC Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

12.2.4. GCC Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

12.3. South Africa

12.3.1. South Africa Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

12.3.2. South Africa Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

12.3.3. South Africa Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

12.3.4. South Africa Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Renal Denervation Revenue (USD Million) and Forecast By Product Type, 2018-2030

12.4.2. Rest of Middle East & Africa Renal Denervation Revenue (USD Million) and Forecast By Technology, 2018-2030

12.4.3. Rest of Middle East & Africa Renal Denervation Revenue (USD Million) and Forecast By Indication, 2018-2030

12.4.4. Rest of Middle East & Africa Renal Denervation Revenue (USD Million) and Forecast By End-User, 2018-2030

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Renal Denervation Market

13.1. Renal Denervation Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Renal Denervation Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. Medtronic PLC

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Million), 2021

14.1.3.2. Medtronic PLC 2021 Renal Denervation Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Cardiosonic, Inc.

14.3. Kona Medical, Inc.

14.4. Abbott Laboratories

14.5. Ablative Solutions, Inc.

14.6. Renal Dynamics

14.7. Mercator MedSystems, Inc.

14.8. ReCor Medical, Inc.

14.9. Boston Scientific Corp.

14.10. Symple Surgical, Inc.